These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26423652)

  • 1. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
    Ahamad K; Hayashi K; Nguyen P; Dobrer S; Kerr T; Schütz CG; Montaner JS; Wood E
    Lancet HIV; 2015 Oct; 2(10):e445-50. PubMed ID: 26423652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs.
    Young SV; Wood E; Dong H; Kerr T; Hayashi K
    Addiction; 2016 Aug; 111(8):1360-5. PubMed ID: 26639363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of length of injecting career on HIV incidence among people who inject drugs.
    Montain J; Ti L; Hayashi K; Nguyen P; Wood E; Kerr T
    Addict Behav; 2016 Jul; 58():90-4. PubMed ID: 26921723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
    Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.
    Nolan S; Hayashi K; Milloy MJ; Kerr T; Dong H; Lima VD; Lappalainen L; Montaner J; Wood E
    Drug Alcohol Depend; 2015 Nov; 156():57-61. PubMed ID: 26455554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
    PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
    Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
    Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.
    Bach P; Wood E; Dong H; Guillemi S; Kerr T; Montaner J; Milloy MJ
    BMC Infect Dis; 2015 Nov; 15():537. PubMed ID: 26586238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
    Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
    J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
    Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
    Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.
    Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T
    J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
    McNeil R; Kerr T; Anderson S; Maher L; Keewatin C; Milloy MJ; Wood E; Small W
    Soc Sci Med; 2015 May; 133():168-76. PubMed ID: 25875323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
    Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
    Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Incidence Among Men Who Have Sex with Men and Inject Drugs in a Canadian Setting.
    Scheim AI; Nosova E; Knight R; Hayashi K; Kerr T
    AIDS Behav; 2018 Dec; 22(12):3957-3961. PubMed ID: 29876756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting.
    Joseph B; Wood E; Hayashi K; Kerr T; Barrios R; Parashar S; Richardson L; Dobrer S; Guillemi S; Montaner J; Milloy MJ
    AIDS; 2016 Mar; 30(6):925-32. PubMed ID: 26636927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia.
    Wood E; Montaner JS; Li K; Zhang R; Barney L; Strathdee SA; Tyndall MW; Kerr T
    Am J Public Health; 2008 Mar; 98(3):515-9. PubMed ID: 18235063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.